Search Within

Mark E Robson

  1. "Psychiatry and Behavioral Sciences, Department of"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (32)
  3. Review (2)
Groups
  1. Breast Medicine Service (75)
  2. Department of Medicine (75)
  3. Population Sciences Research Program (75)
  4. Psychiatry and Behavioral Sciences, Department of (75)
  5. Solid Tumor Oncology Division (75)
  6. Survivorship Research (75)

More Groups

People
  1. Jada Hamilton (45)
  2. Kenneth Offit (44)
  3. Larry Norton (14)
  4. Teresa Gilewski (14)
  5. Jennifer Hay (13)
  6. Erin Salo-Mullen (11)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (6)
  4. 2021 (6)
  5. 2020 (9)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Annals of Behavioral Medicine (7)
  3. Breast Cancer Research and Treatment (5)
  4. Cancer Research (5)
  5. Genetics in Medicine (4)
  6. JCO Precision Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Springer (14)
  3. American Association for Cancer Research (8)
  4. Nature Publishing Group (6)
  5. Elsevier Inc. (5)
  6. BMJ Publishing Group Ltd. (3)

More Publishers

Results (75)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Impact of risk-reducing oophorectomy on quality of life in women at risk for ovarian cancer
    Meeting Abstract

    McArthur, H. L.; Hensley, M.; Brown, C. L.; Chi, D. S.; Offit, K.; Hurley, K.; Li, Y.; Gemignani, M. L.; Robson, M. E.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Protecting the privacy of third-party information: Recommendations for social and behavioral health researchers
    Journal Article

    Lounsbury, D. W.; Reynolds, T. C.; Rapkin, B. D.; Robson, M. E.; Ostroff, J.
    Social Science and Medicine (2007)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Ovarian carcinoma screening in women at intermediate risk: Impact on quality of life and need for invasive follow-up
    Journal Article

    Kauff, N. D.; Hurley, K. E.; Hensley, M. L.; Robson, M. E.; Lev, G.; Goldfrank, D.; Castiel, M.; Brown, C. L.; Ostroff, J. S.; Hann, L. E.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: Anxiety, risk perceptions, and quality of life
    Journal Article

    Hensley, M. L.; Robson, M. E.; Kauff, N. D.; Korytowsky, B.; Castiel, M.; Ostroff, J.; Hurley, K.; Hann, L. E.; Colon, J.; Spriggs, D.
    Gynecologic Oncology (2003)

    Fulltext@MSK | Save